-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Yimaitong compiles and arranges, please do not reprint
without authorization.
Retinal microangiopathy (DR) is a classic diabetes-related complication that can lead to
in severe cases.
The study found that DR can also occur in "pre-diabetic" people, and
7% increase in HbA1c increases the risk of DR by 92%)
.
The findings were published in
Diabetes Care.
During the Diabetes Prevention Program (DPP) and DPP Outcome Study (DPPOS), fundus photography
was performed on adults at high risk of T2D, including those who already had diabetes.
Fundus photographs were graded using the ETDRS grading system, which defined as typical lesions (
in any eye.
"Slightly
By DPPOS year 16, 24% of 1614 T2D subjects and 14% of 885 non-diabetic subjects developed DR.
In univariate analysis, American Indian populations had significantly lower
DR events compared to non-Hispanic whites (NHWs).
Higher blood glucose levels (HbA1c, fasting, OGTT 2-hour blood glucose), greater body weight,
more frequent DR events.
Multivariate analysis showed that the US Indian population had significantly fewer DR events compared with NHW (OR 0.
36, 95% CI 0.
20-0.
66), higher mean HbA1c levels were significantly associated with more DR events (OR 1.
92, 95% CI 1.
46-1.
74), and a 92% increase in DR risk for every 0.
7%
increase in HbA1c.
Table 1 Indian population and mean HbA1c level are important risk factors for DR
Summary of this article
After more than ten years of follow-up, it has been found that
7% increase in HbA1c, suggesting clinical attention
.
Compiled by Neil H.
White, Qing Pan, William C.
Knowler, et al.
Diabetes Prevention Program Outcome Study (DPPOS) Research Group:; Risk Factors for the Development of Retinopathy in Prediabetes and Type 2 Diabetes: The Diabetes Prevention Program Experience.
Diabetes Care 1 November 2022; 45 (11): 2653–2661.
https://doi.
org/10.
2337/dc22-0860